| Print
Harvard Bioscience (HBIO)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
Address
84 October Hill Road
Suite 10
Holliston
MA
USA
01746
Telephone
+1 508 8938999
Forecast key dates
| Name | Key Date |
|---|---|
| Harvard Bioscience Inc Third Quarter Earnings Conference Call for 2026 | 2026-11-06T08:00:00 |
| Harvard Bioscience Inc Third Quarter Earnings Results for 2026 | 2026-11-06T00:00:00 |
| Harvard Bioscience Inc Second Quarter Earnings Conference Call for 2026 | 2026-08-11T08:00:00 |
| Harvard Bioscience Inc Second Quarter Earnings Results for 2026 | 2026-08-11T00:00:00 |
| Harvard Bioscience Inc Annual General Meeting for 2026 | 2026-06-02T11:30:00 |
| Harvard Bioscience Inc First Quarter Earnings Conference Call for 2026 | 2026-05-12T08:00:00 |
| Harvard Bioscience Inc First Quarter Earnings Results for 2026 | 2026-05-12T00:00:00 |
| Harvard Bioscience Inc Annual Report for 2025 | 2026-03-13T00:00:00 |
| Harvard Bioscience Inc Fourth Quarter Earnings Conference Call for 2025 | 2026-03-12T08:00:00 |
| Harvard Bioscience Inc Fourth Quarter Earnings Results for 2025 | 2026-03-12T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Harvard Bioscience Inc Third Quarter Earnings Conference Call for 2025 | 2025-11-06T08:00:00 |
| Harvard Bioscience Inc Third Quarter Earnings Result for 2025 | 2025-11-06T00:00:00 |
| Harvard Bioscience Inc Second Quarter Earnings Conference Call for 2025 | 2025-08-11T08:00:00 |
| Harvard Bioscience Inc Second Quarter Earnings Results for 2025 | 2025-08-11T00:00:00 |
| Harvard Bioscience Inc Annual General Meeting for 2025 | 2025-06-02T11:30:00 |
| Harvard Bioscience Inc First Quarter Earnings Conference Call for 2025 | 2025-05-12T08:00:00 |
| Harvard Bioscience Inc First Quarter Earnings Result for 2025 | 2025-05-12T00:00:00 |
| The KeyBanc Capital Market | 2025-03-19T15:45:00 |
| 37th Annual Roth Conference | 2025-03-17T10:00:00 |
| Harvard Bioscience Inc Annual Report for 2024 | 2025-03-14T00:00:00 |
| Harvard Bioscience Inc Fourth Quarter Earnings Conference Call for 2024 | 2025-03-12T08:00:00 |
| Harvard Bioscience Inc Fourth Quarter Earnings Result for 2024 | 2025-03-12T00:00:00 |
| Sidoti Micro Cap Conference | 2025-01-22T10:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.